For the Indian pharma sector, 2016 is seen as a year of hope for further growth boosted by a better US and domestic market, with many policy decisions lined up
For the Indian pharma sector, 2016 is seen as a year of hope for further growth boosted by a better US and domestic market, with many policy decisions lined up
Please to comment